Setting the Record Straight on Long-Term Use, Dose Escalation, and Potential Misuse of Prescription Benzodiazepines

Stephen B Soumerai,Mahnum Shahzad,Carl Salzman,Stephen B. Soumerai
DOI: https://doi.org/10.1176/appi.ajp.20240030
IF: 17.7
2024-03-03
American Journal of Psychiatry
Abstract:The potential for misuse of benzodiazepines and benzodiazepine-related drugs (hereafter, BZRAs) has been a source of controversy for over five decades. These medications can be used for patients with anxiety, panic and sleep disorders, and seizure disorders (1). They are commonly coprescribed with antidepressants and antipsychotic medications to treat the associated anxiety and sleep disturbances of these psychiatric disorders. When carefully prescribed to patients who are not substance abusers, benzodiazepines are rapidly effective and safe. The known pharmacology of these medications adds to their safety by allowing selection of a particular benzodiazepine based on elimination half-life and cytochrome enzyme metabolism. However, benzodiazepines are not without risks. They share dose-dependent side effects with other sedative-hypnotic drugs and may augment both positive and negative side effects of the primary medication. These include sedation, unsteadiness (falls in the elderly), mild physiological dependence with chronic use, and mild to moderate discontinuation symptoms when abruptly discontinued. Whether long-term benzodiazepine use interferes with memory and other cognitive abilities is controversial, but the available evidence suggests that benzodiazepines do not cause Alzheimer's disease (1).
psychiatry
What problem does this paper attempt to address?